全球植入式输液港市场 - 市场规模（依细分市场划分）、占有率、监管、报销、干预措施及预测（至 2036 年）

本报告调查并分析了全球植入式输液港市场，提供了依地区划分的市场规模、关键趋势、创新产品和技术以及竞争格局等资讯。

市场模型的主要组成如下：

已上市的植入式输液港及不断变化的竞争格局

• 关键产业趋势探讨
• 植入式输液港市场各细分市场的年度收入及市场展望（2015-2036 年）
• 市场层面的销售、平均售价和市场价值数据

全球、区域与国家层面各市场的探讨

• 依地区和国家划分的定性市场讯息，以及全球市场探讨趋势
• 植入式输液港市场 SWOT 分析
• 植入式输液港市场竞争格局与趋势探讨

全面深入的视角，包括对医疗保健系统的概述，有助于更好地理解市场。此外，市场参与情况部分提供了有关报销政策和监管环境的信息，从而可以更深入地了解市场动态。

• 各国医疗保健系统概述
• 报销政策
• 医疗科技监管环境

目标公司

• CR Bard Inc
• AngioDynamics Inc
• B. Braun Melsungen AG
• Teleflex Inc
• Vygon SA
• A.M.I. GmbH
• 其他

Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Drug Delivery Devices therapeutic area.

Implantable ports, also called portacaths or subcutaneous ports, are used to administer chemotherapy, medicine, fluids, and nutrients, or take blood samples. An Implantable Port is a catheter with a small reservoir (port) attached to it. Port devices are prescribed for patients, who require long-term intravenous therapy.

Cancers, also known as malignancies are the abnormal growth of cells which can spread to parts of the body. Oncologic patients may require intermittent administration of chemotherapy, parenteral nutrition, infusions, or blood transfusions.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications and intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Implantable Ports and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Implantable Ports market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Implantable Ports market.
• Competitive dynamics insights and trends provided for Implantable Ports market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: CR Bard Inc, AngioDynamics Inc, B. Braun Melsungen AG, Teleflex Inc, Vygon SA, A.M.I. GmbH, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Implantable Ports marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Implantable ports market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Implantable ports market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Implantable ports market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.